Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies

被引:0
作者
Wei-qun Xu
Ling-yan Zhang
Xue-ying Chen
Bin-hua Pan
Jun-qing Mao
Hua Song
Jing-yuang Li
Yong-min Tang
机构
[1] Children’s Hospital of Zhejiang University,Division of Hematology
[2] School of Medicine,Oncology
来源
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词
High-dose methotrexate; Elimination delay; Acute lymphoblastic leukemia; Childhood; Non-Hodgkin lymphoma; Creatinine clearance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:79 / 86
页数:7
相关论文
共 50 条
  • [31] Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review
    Daetwyler, Eveline
    Bargetzi, Mario
    Otth, Maria
    Scheinemann, Katrin
    BMC CANCER, 2022, 22 (01)
  • [32] High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia
    T V Ch Skärby
    H Anderson
    J Heldrup
    J A Kanerva
    H Seidel
    K Schmiegelow
    Leukemia, 2006, 20 : 1955 - 1962
  • [33] High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate
    Chladkova, Jirina
    Hak, Jiri
    Martinkova, Jirina
    Chladek, Jaroslav
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2010, 60 (12): : 769 - 775
  • [34] High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies:: do we really know why, when and how?
    Sterba, J
    Valík, D
    Bajciová, V
    Kadlecová, V
    Gregorová, V
    Mendelová, D
    NEOPLASMA, 2005, 52 (06) : 456 - 463
  • [35] Monitoring and Treatment of Acute Kidney Injury in Children with Acute Lymphoblastic Leukemia After High Dose Methotrexate Chemotherapy
    Wang, Cong-Ping
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (04): : 957 - 961
  • [36] Identification of Risk Factors in High-Dose Methotrexate-Induced Acute Kidney Injury in Childhood Acute Lymphoblastic Leukemia
    Cheng, Dao-Hai
    Lu, Hua
    Liu, Tao-Tao
    Zou, Xiao-Qin
    Pang, Hui-Mei
    CHEMOTHERAPY, 2018, 63 (02) : 100 - 106
  • [37] Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review
    Eveline Daetwyler
    Mario Bargetzi
    Maria Otth
    Katrin Scheinemann
    BMC Cancer, 22
  • [38] Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia
    Csordas, Katalin
    Hegyi, Marta
    Eipel, Oliver T.
    Muller, Judit
    Erdelyi, Daniel J.
    Kovacs, Gabor T.
    ANTI-CANCER DRUGS, 2013, 24 (02) : 189 - 197
  • [39] Comparison of Capizzi and High-dose Methotrexate Approaches in the Treatment of Pediatric B-cell Acute Lymphoblastic Leukemia
    Gungoren, Ezgi Yalcin
    Koc, Basak
    Zulfikar, Bulent
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2025, 47 (02) : 67 - 73
  • [40] Evaluation of serum and urine fetuin-A levels in children with acute lymphoblastic leukemia during and after high-dose methotrexate therapy: Relation to toxicity
    Ragab, Seham M.
    Badr, Eman A.
    HEMATOLOGY, 2016, 21 (02) : 78 - 91